Patents by Inventor Susan Schwendner

Susan Schwendner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070248692
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent.
    Type: Application
    Filed: March 16, 2007
    Publication date: October 25, 2007
    Applicants: AMGEN INC., HEALTH RESEARCH, INC.
    Inventors: Fengzhi Li, Xiang Ling, Youcef Rustum, Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Publication number: 20070231406
    Abstract: The invention provides methods, compositions, and kits for treatment or prevention of biofilm-associated infections in an individual. Methods of the invention include administration of a gallium-containing composition for treatment of an established biofilm or prevention of formation of a biofilm. Some methods include administration of a gallium-containing composition in conjunction with an antibiotic substance. Some methods include treatment or prevention of an orally-associated biofilm with a gallium-containing composition in the form of a dentrifice, mouthwash, or chewing gum composition.
    Type: Application
    Filed: January 30, 2007
    Publication date: October 4, 2007
    Inventors: Louis Bucalo, Susan Schwendner, Uwe Wirtz, Sunil Sreedharan
  • Publication number: 20050250854
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent.
    Type: Application
    Filed: November 23, 2004
    Publication date: November 10, 2005
    Applicants: Amgen Inc., Health Research, Inc.
    Inventors: Fengzhi Li, Xiang Ling, Youcef Rustum, Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Patent number: 6822001
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: November 23, 2004
    Assignee: Tularik Inc.
    Inventors: Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Publication number: 20020177548
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.
    Type: Application
    Filed: November 2, 2001
    Publication date: November 28, 2002
    Applicant: Tularik Inc.
    Inventors: Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Patent number: 6355628
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic platinum coordination complex such as cisplatin.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: March 12, 2002
    Assignee: Tularik Inc.
    Inventors: Susan Schwendner, Pieter Timmermans, Jacqueline Walling